ImetelChat

Christine Hlavka - Senior Director, Intellectual Property at Geron Corporation Hired - Sept. 2024 Former Employers include: Alexion Pharmaceuticals, Rhodes Pharmaceuticals, Bookoff McAndrews PLLC, Finnegan-Henderson-Farabow-Garrett & Dunner LLP, Foley & Lardner LLP *We are all well aware of Geron's ...

https://www.linkedin.com/posts/medialis ... er_android


https://medialis.co.uk/

HBean was a central figure of support, volunteering endless hours to Tyler and his family in the past few months during his battle with AML. Thank you HBean for your commitment to those patients who find themselves in situations most of us can never fathom. I for one am very much looking forward to ...

HBean - thank you for your insight. You are correct that it is an exciting time as far as opportunities for treatment with patients and providers is concerned. Geron and Rytelo fill an ever growing niche with a global population not fully recognized. As investors I think we're going to need a bigger...

HBean - In the last Quarterly CC on 8/8, Geron had mentioned having an internal company resource for patients and providers to help navigate assistance with financial aspects of treatment. Is this a routine obligation for Biotech / Pharma, or a trend we shall see become commonplace? First time I was...

He's been there for almost 2 years. He most definitely wasn't lured away. -Kmall

https://investor.verastem.com/news-rele ... directors/

HI - Every profession has nuance understandings and lingo that when you're in that world are second nature - a doctor, lawyer, ditch digger, etc; very quickly after corresponding with Hbean, I learned
I didn't know s*it. -Kmall

Very much looking forward to the newest board member, Hbean contributing to I-Chat. Unfortunately she is with Tyler's family at the moment, paying respects at his service. With over 3 decades of post approval marketing in Big Pharma, she has a good deal on insight into the inner workings of the wate...

It has been well over a year, closer to two actually, since Geron has had any additional hires in the UK. Just yesterday, Geron contracted out a Regulatory Data Specialist there. Notably, as either Ryan or RC had brought to our attention earlier (forgive me for not recalling who), there doesn't appe...

HI - tremendous find!! This oral agent will be a total game changer for patients and Geron.

Interesting to take a look back at this now. I believe the $1.5B estimate for peak sales by 2026 was both MDS and MF. -Kmall

https://www.trefis.com/no-login-required/EGjsiPc5

HI - Solid analysis of where a valuation of Geron stands at the moment. Sales projections for all indications are quite conservative when you look at global patient populations. Various reasons why they are easily double if not more in many parts of the world with the numbers potential annual revenu...

There is never an easy way to tell horrible news to someone. About an hour ago I learned that Tyler had passed. As of yesterday it was apparent that his body had given it's last fight. A 20 month long battle, ending in every parents worst nightmare. Tyler was a ray of sunshine for his family. A real...

Flannel on the YMB pointed out that the IMpress AML Clinical Trial is now back to its original 46 patient enrollment design. I know there was discussion here on a data review at the 23 patient midway point. Any additional thoughts? I'm going out on a limb here by saying no news is good news for now?...

Ryan - excellent point. They like to announce Executive hires bright and early @ 8am......most likely get that Tuesday morning. -Kmall

HI - Does it feel like Occam through him under the bus just a little bit?


"Then, in the summer of 2024, Geron received FDA approval. And with a commercial launch on the horizon, Occam completed the puzzle by appointing a Chief Commercial Officer."

Ryan - Nice catch!!! I totally overlooked that. Looks like they're waiting to announce. Anil's profile has been removed from the Geron website.....I suspect we get an announcement sometime next week.... perhaps Thursday? Pattern would favor that day. -Kmall

Geron has utilized Executive Search firm Occam on several occasions since going solo from JNJ in 2018.......so much so that Geron has warranted its own case study. https://www.occam-global.com/project/geron Occam has previously placed three independent Board members, John, McDonald, Dawn Bir, and Li...